Bayer CropScience To Acquire So. American Biological Seed Treatment Developer
BAYER CROPSCIENCE TO ACQUIRE SO. AMERICAN BIOLOGICAL SEED TREATMENT DEVELOPER Mar. 7, 2014 Source: Bayer CropScience news release Bayer CropScience has signed an agreement to acquire Biagro Group, headquartered in Gral Las Heras, Provincia de Buenos Aires/Argentina, a producer and distributor of biological seed treatment solutions.
Trending on the Topix Network
DGAP-DD: Bayer Aktiengesellschaft english
Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors' Dealings notification transmitted by DGAP - a company of EQS Group AG.
Thu Mar 06, 2014
Bayer completes voluntary takeover offer for Algeta
Payment of the offer price has been made to shareholders who accepted the takeover offer and, at the same time, the 43,131,641 tendered shares have been transferred to Bayer.
Mon Mar 03, 2014
Bayer Sets New Sales Record In Anniversary Year
The Bayer Group posted a strong fiscal report for 2013, setting a new record in sales and forecasting further growth in sales and earnings for 2014.
Week in Review: To Stage Hong Kong IPO
More detailsa . Stock Symbols: Help employers find you! Check out all the jobs and post your resume .
Fri Feb 28, 2014
Business News Briefs: Foundation hits milestone
The Pittsburgh Foundation's assets totaled $1.05 billion at the end of 2013, surpassing the $1 billion mark for the first time.
Bayer AG Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs
Germany's largest drugmaker Bayer lifted its estimate for potential sales of new drugs by billions of euros on Friday, softening the blow of a fall in fourth-quarter earnings.
Bayer HealthCare's SerestoA voted best new flea and tick...
Seresto A , winner of a 2014 Better Homes and Gardens Best New Product Award,1 provides dog or cat owners with the performance they expect from a monthly flea and tick topical in an easy-to-use convenient collar that protects for eight months with only one application.
The Washington Post
Bayer Raises Drug Sales Forecast as Fourth-Quarter Profit Lags
Bayer AG raised its forecast for peak sales of new drugs such as the blood thinner Xarelto even as fourth-quarter results and the revenue outlook for this year missed analyst estimates.
Thu Feb 27, 2014
Bayer CropScience Second Annual Bee Care Tour Fosters Discussion and Awareness at Commodity Classic
The mobile tour is traveling coast-to-coast to create awareness of the vital role of honey bees in sustainable agriculture by establishing a dialogue with growers, beekeepers, researchers and students to discuss the multiple factors affecting honey bee health.
Bayer Buys China's Dihon to Gain OTC and Herbal Therapies
Bayer AG agreed to buy Dihon Pharmaceutical Group Co. to gain Chinese over-the-counter products and traditional herbal treatments as drug companies expand in Asia .
Wed Feb 26, 2014
Minnesota Farmer Bryan Boll Recognized For Building a Successful Business, Protecting the Land
Along the way, he adopted state-of-the-art conservation practices to protect highly erodible land and embraced precision agriculture, utilizing satellite navigation and GPS.
Erectile Dysfunction Drugs Market - Forecast to 2019
The erectile dysfunction drugs market is expected to witness a decline across the globe, by the end of the forecast period, i.e. by 2019, due to patent expiration of the key revenue generating drug Viagra outside the U.S. in 2013.
Ag Issues Forum Addresses 'What the World Needs'
The challenge facing agriculture is a formidable one: meet the food, fiber and fuel needs of more than 9 billion people by 2050, all while minimizing the environmental footprint of farming, explains "What's in play here is really a question of global food security," he says.
Tue Feb 25, 2014
Coexistence of Trade Mercks? An expert writes ...
On Monday, in "Preliminary hearing to rule on Merck-y past", a blogpost on an interim ruling in a trade mark infringement trial before the courts of England and Wales involving the two Merck pharma companies, Merpel asked why anyone should want to use the word MERCK in the first place.
Biotech Bayer Does Face Plant
Media coverage from our hometown newspaper, Corvallis Gazette Times, with the headline, Pesticide Debate Creates a Buzz at OSU , was not quite the public relations that Bayer sought.
GreenLight Biosciences Announces New Partnership with Bayer CropScience
GreenLight's assets can enable a new safe, fast, energy efficient and economical way of manufacturing crop protection products through bacteria which have been engineered to produce enzymes for cell-free chemical synthesis processes.
Mon Feb 24, 2014
Bayer AG Clinches $2.9 Billion Deal For Norway's Algeta
German drug firm Bayer has clinched a $2.9 billion deal to take over Norwegian cancer drug maker Algeta after being tendered 92.17 percent of the shares in a cash offer, the companies said on Monday.
Thu Feb 20, 2014
Bayer AG Initiates Phase III Trial Of Stivarga (Regorafenib)...
Bayer AG Initiates Phase III Trial Of Stivarga Tablets In Patients With Colorectal Cancer After Resection Of Liver Metastases /PRNewswire/ -- Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying StivargaA tablets in colorectal cancer patients with resected liver metastases.
Wed Feb 19, 2014
Market Chatter- Corporate finance press digest
* France's EDF is seeking to sell 70 percent of Italian unit Edison's wind farm operations as it looks to bring on board a financial partner to help to fund expansion, three sources close to the matter said on Wednesday.